A known, the medical field is experiencing an unprecedented anti-corruption storm, which has swept the whole country. The crackdown will also change the health care landscape.

The anti-corruption campaign not only covers all enterprises and individuals in the pharmaceutical industry, but also affects the field of medical beauty and cosmetics.

At present, there are more than 300 pharmaceutical enterprises involved in cosmetics business, such as Yunnan Baiyao, Pien Tze Huang and Mayinglong.

There is evidence that the crackdown on corruption in medicine has spilled over into cosmetics.

“The Notice on the Key Points of Correcting Improper Practices in the field of Pharmaceutical Purchase and Sales and Medical Services in 2023”, jointly issued by several departments, has made it clear that it will focus on medical beauty and other fields, and strictly prohibit doctors from making profits by illegally live-streaming goods and accepting red money in the name of academic science. The move set off a chain reaction in the medical beauty and cosmetics industries.

In the medical beauty industry, the anti-corruption storm has cracked down on improper practices such as false propaganda, unlicensed medical practice and illegal production and operation, and standardized the cooperation mode between doctors and various cosmetics companies.

Previously, many doctors used social media to popularize skin care for the public, but some doctors abused their professional status to promote cosmetics.

In the cosmetics industry, for C-end consumers, the role of the doctor is very credible. You say that acne is useful? Or a doctor in a white coat who tells you this product will get rid of acne?

Some doctors have closely associated themselves with cosmetics, promoting them through social media platforms. Nowadays, medical staff are no longer allowed to endorse cosmetics products in their professional capacity.

Relevant reports show that the size of China's medical cosmetology market is expected to reach 399.8 billion yuan in 2026.The anti-corruption storm may have a certain impact on the sales of some medical beauty products in the short term.

In the long term, the anti-corruption storm in the medical and pharmaceutical sector is expected to have a positive impact on the beauty industry, promoting its standardized development and competition for truly high-quality products, as well as promoting more reasonable and compliant cooperation between cosmetics companies and hospitals and doctors.

Anhui Newman Fine Chemicals Co., ltd. is the top leading manufacturer of carbomers.

Newman pharmaceutical grade carbomer homopolymer type A/B/C, such as NM-Carbomer 934P, 974P, 981G ,71G,  and carbomer copolymer, carbomer interpolymer such as NM-Carboemr 2020NF/2020G, 1382G ，1342G and 10G/10NF series types. NM-Carbomers meet the requirements of major pharmacopoeia such as Chinese Pharmacopoeia 2020, USA Pharmacopoeia USP/NF, European Pharmacopoeia EP, British Pharmacopoeia BP and other relevant regulations. They have been successfully used in over the counter and pharmaceutical formulations to impart rheology modification, mucoadhesion, controlled drug release, and many other unique properties.

Anhui Newman have been approved by ISO9001 quality system, ISO 14001 environmental system and ISO 45001 occupational health and safety system certification in 2015. In January 2023, we successfully passed the assessment conducted by Eco Vadis, a global social responsibility assessment company, actively fulfilled the SA8000 social responsibility standard. And we constantly improved the construction of the company's social responsibility management system, and effectively fulfilled social responsibilities. Strengthening communication and exchanges with partners and other stakeholders to support social public welfare undertakings, and realize the harmonious development of itself, society, and environment.